| abstract |
The present invention relates to a sustained release formulation comprising a metastin derivative and a glycolic acid lactic acid copolymer having a weight average molecular weight of about 5,000 to about 40,000 or a salt thereof. The sustained release formulation of the present invention slowly and stably releases the compound (I) or a salt thereof for a long time and exerts a medicinal effect of the compound (I) or a salt thereof for an extended period of time. In addition, the sustained release formulation of the present invention, which improves patient convenience by reducing the number of episodes of administration, is an excellent formulation as a clinical medicine. |